Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lefancaps is a private, active capsule manufacturing and drug delivery technology company serving pharmaceutical, nutraceutical, and healthcare customers. The company focuses on empty hard capsule solutions, including gelatin, hypromellose (HPMC), pullulan, enteric, DPI, clinical, preclinical, and liquid-filled capsule formats. In addition to capsule supply, Lefancaps offers customization, formulation support, weight inspection, liquid-filling services, equipment maintenance, and support for CRO, CMO, and CDMO workflows. The business appears to operate through U.S. and China entities, with manufacturing centered in Jiangsu, China and commercial operations in Ontario, California. Its business model is business-to-business manufacturing and enabling services rather than development of proprietary therapeutic drug pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lefancaps.